C J Gelatine Products Ltd
Established in 1982, C.J. Gelatine Products Ltd is engaged in the business of manufacturing of Gelatine and related by-products like Di-Calcium Phosphate, Ossein, etc.
- Market Cap ₹ 7.94 Cr.
- Current Price ₹ 16.5
- High / Low ₹ 29.7 / 14.0
- Stock P/E 99.2
- Book Value ₹ 8.68
- Dividend Yield 0.00 %
- ROCE 5.86 %
- ROE 1.79 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.86% over past five years.
- Company has a low return on equity of 6.95% over last 3 years.
- Company might be capitalizing the interest cost
- Debtor days have increased from 28.5 to 36.1 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
14.93 | 17.76 | 22.56 | 16.55 | 23.01 | 25.81 | 28.28 | 39.03 | 39.53 | 36.80 | 40.89 | 41.29 | |
14.66 | 16.47 | 20.86 | 16.66 | 21.84 | 23.91 | 26.59 | 37.15 | 37.46 | 35.20 | 38.98 | 39.61 | |
Operating Profit | 0.27 | 1.29 | 1.70 | -0.11 | 1.17 | 1.90 | 1.69 | 1.88 | 2.07 | 1.60 | 1.91 | 1.68 |
OPM % | 1.81% | 7.26% | 7.54% | -0.66% | 5.08% | 7.36% | 5.98% | 4.82% | 5.24% | 4.35% | 4.67% | 4.07% |
0.24 | 0.00 | 0.10 | 0.18 | 0.23 | -0.16 | 0.06 | 0.02 | 0.04 | 0.59 | -2.55 | 0.35 | |
Interest | 0.51 | 0.87 | 1.32 | 1.74 | 0.96 | 0.86 | 1.13 | 1.07 | 1.22 | 1.37 | 1.37 | 1.26 |
Depreciation | 0.20 | 0.34 | 0.30 | 0.34 | 0.36 | 0.37 | 0.38 | 0.43 | 0.48 | 0.50 | 0.55 | 0.58 |
Profit before tax | -0.20 | 0.08 | 0.18 | -2.01 | 0.08 | 0.51 | 0.24 | 0.40 | 0.41 | 0.32 | -2.56 | 0.19 |
Tax % | 0.00% | 12.50% | 33.33% | 0.00% | 12.50% | 25.49% | 12.50% | 12.50% | 14.63% | 28.12% | -24.22% | 57.89% |
-0.20 | 0.06 | 0.13 | -2.01 | 0.06 | 0.37 | 0.22 | 0.35 | 0.35 | 0.23 | -1.95 | 0.08 | |
EPS in Rs | -0.42 | 0.12 | 0.27 | -4.18 | 0.12 | 0.77 | 0.46 | 0.73 | 0.73 | 0.48 | -4.05 | 0.17 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 8% |
3 Years: | 1% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | -8% |
5 Years: | -18% |
3 Years: | -39% |
TTM: | -91% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 16% |
3 Years: | -3% |
1 Year: | -22% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 6% |
3 Years: | 7% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 |
Reserves | 8.31 | 7.74 | 7.30 | 4.73 | 4.22 | 4.03 | 3.69 | 2.97 | 2.75 | 2.42 | -0.08 | -0.63 |
1.64 | 1.83 | 6.00 | 7.68 | 5.37 | 5.01 | 9.93 | 12.83 | 18.57 | 19.55 | 19.61 | 20.96 | |
6.92 | 9.41 | 9.78 | 14.68 | 17.69 | 17.05 | 12.56 | 11.95 | 8.67 | 8.68 | 8.76 | 7.69 | |
Total Liabilities | 21.68 | 23.79 | 27.89 | 31.90 | 32.09 | 30.90 | 30.99 | 32.56 | 34.80 | 35.46 | 33.10 | 32.83 |
10.51 | 9.54 | 9.48 | 9.26 | 8.66 | 8.04 | 7.42 | 7.09 | 7.27 | 7.15 | 6.52 | 5.96 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
11.17 | 14.25 | 18.41 | 22.64 | 23.43 | 22.86 | 23.57 | 25.47 | 27.53 | 28.31 | 26.58 | 26.87 | |
Total Assets | 21.68 | 23.79 | 27.89 | 31.90 | 32.09 | 30.90 | 30.99 | 32.56 | 34.80 | 35.46 | 33.10 | 32.83 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.92 | 0.69 | 0.78 | 1.11 | 2.15 | 1.30 | -6.19 | -3.34 | -4.07 | 0.80 | 1.76 | 0.46 | |
-0.03 | 0.00 | -0.80 | -0.68 | -0.33 | -0.32 | -0.26 | -0.65 | -1.18 | -0.36 | -0.44 | -0.55 | |
-0.90 | -0.68 | 1.58 | -0.47 | -3.25 | -0.59 | 6.01 | 3.98 | 4.50 | -0.45 | -1.31 | 0.09 | |
Net Cash Flow | -0.01 | 0.01 | 1.56 | -0.04 | -1.42 | 0.40 | -0.43 | -0.01 | -0.75 | -0.01 | 0.00 | 0.00 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 19.80 | 29.59 | 33.01 | 77.85 | 67.57 | 53.88 | 31.62 | 23.94 | 34.26 | 20.73 | 28.74 | 36.07 |
Inventory Days | 421.33 | 424.77 | 375.37 | 629.85 | 430.58 | 395.32 | 414.65 | 275.60 | 274.00 | 326.34 | 249.08 | 236.58 |
Days Payable | 274.43 | 301.12 | 247.26 | 514.05 | 399.89 | 352.31 | 233.33 | 129.87 | 75.28 | 77.99 | 36.31 | 48.50 |
Cash Conversion Cycle | 166.70 | 153.25 | 161.12 | 193.65 | 98.26 | 96.89 | 212.93 | 169.68 | 232.97 | 269.08 | 241.50 | 224.15 |
Working Capital Days | 103.41 | 98.65 | 93.19 | 103.88 | 62.34 | 47.94 | 130.23 | 111.66 | 166.66 | 185.28 | 162.19 | 173.00 |
ROCE % | 0.65% | 7.55% | 9.05% | -1.75% | 6.58% | 10.97% | 8.49% | 7.53% | 6.97% | 6.39% | 6.26% | 5.86% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - Attached is the extract of newspapers, wherein, financial results of the company for the period ended March 31, 2025 has been published in prescribed format.
-
Appointment Of Internal Auditors
30 May - Appointed M/s Prem Chand Jain & Co. as internal auditor for FY 2025-26.
- The Quarter And Financial Year Ended On March 31, 2025 Alongwith Auditor Report. 30 May
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On Friday, May 30, 2025
30 May - Audited financial results for FY ended March 31, 2025 approved with unmodified audit opinion.
-
Board Meeting Intimation for A Meeting To Be Held On Friday, May 30, 2025 At 1:30 P.M. (IST).
22 May - Board meeting on May 30, 2025, to approve audited financial results for FY ended March 31, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Overview:[1]
Gelatin is the main ingredient in empty capsules and soft-gel capsules. As a rich source of protein, Gelatin finds application in numerous end use sectors including pharma, food and beverage, photographic supplies, cosmetics, explosives, electroplating, dyes, papermaking and printing.
Gelatin capsules hold major market share in empty capsule markets. Gelatin provides rapid drug release and excellent oxygen barrier and hence are preferred for manufacturing capsule shells.